NCT07670468: Evaluation of the Safety and Efficacy of LB-DTK-MV in Patients Diagnosed With Antiviral-Resistant CMV, BKV, or EBV Infection or Associated Diseases Following Anticancer Therapy or Allogeneic Hematopoietic Stem Cell Transplantation.
- State
- Under way
- Phase
- Phase 1 and Phase 2
- People
- 27 planned
- Started
- 4 Dec 2025
- Primary completion
- 4 Jun 2027
- Arms
- Experimental Group (All)
- Results
- None posted
- 4 Dec 2025: Trial started
- 26 Jun 2026: Trial registered